Clinical Research & Clinical Trial Management | Project Owner

How Many Software Systems Does One Clinical Trial Actually Need? Ask someone outside the industry to guess how many software systems a single clinical trial runs on, and they'll probably say two or three: something to collect patient data, something to manage the study. Ask someone who actually staffs a site, and the answer is closer to twenty. This isn't exaggeration. It's documented, repeatedly, across multiple independent industry surveys. And once you start counting, the financial and human cost of that sprawl becomes hard to ignore. The inventory: what actually runs a trial A realistic multi-site trial typically touches systems across at least six layers: Core eClinical systems EDC (Electronic Data Capture) for patient-level data collection CTMS (Clinical Trial Management System) for enrollment, site performance, milestones, budgets RTSM/IRT for randomization and drug supply management eTMF for trial master file / regulatory document repository eConsen...

As large language models (LLMs), GenAI, workflow automation, and integrated operational platforms continue to evolve, an increasingly uncomfortable question is beginning to emerge within clinical research: Why are so many additional organizational, management, and software layers still required to run clinical trials? For decades, CROs have played a central role in pharmaceutical research. Historically, this made complete sense. Pharmaceutical companies needed global operational infrastructure, therapeutic expertise, monitoring capacity, regulatory operations, staffing, laboratory services, and the ability to rapidly execute increasingly complex multinational clinical trials. However, modern clinical trial operations have also become heavily fragmented. Today, Sponsors, CROs, vendors, laboratories, and sites often maintain overlapping operational systems, duplicated reporting layers, reconciliation trackers, parallel oversight structures, and multiple disconnected software environments...

(Please drop a comment or reach out if you would like to discuss the development of this concept, exchange ideas, validate assumptions, or explore potential collaboration opportunities.) Over the last weeks, I have been experimenting with AI-assisted development platforms such as Codex and Base44 to explore whether integrated clinical trial budgeting and operational planning concepts can now be prototyped much faster than traditionally possible with multiple disconnected systems. As an educational proof-of-concept, I used publicly available clinical trial protocol examples to generate prototype Clinical Trial Budgeting and Project Management environments (links below). The broader goal is not to create a validated production system at this stage, but rather to explore whether a lightweight educational platform could eventually help research groups, startups, CROs, and biotech teams: estimate study budgets, evaluate operational feasibility, understand budget drivers, model resource requ...

Is cross-system clinical trial automation failing not because workflows cannot be executed, but because protocol terminology cannot be interpreted consistently across systems and clinical studies? Discussions about automating clinical trials often focus on advanced technologies such as workflow engines, interoperability standards, and AI/ML. In practice, cross-system automation most often breaks much earlier, at a far more basic level: inconsistent naming conventions .  Clinical protocols are written in natural language, where the same term can legitimately carry different meanings depending on study design, therapeutic area, or regulatory intent. Software systems, by contrast, assume that identifiers are stable, explicit, and unambiguous. This mismatch creates friction long before questions of execution logic or governance arise. Several academic and industry initiatives have proposed encoding protocol elements, such as eligibility criteria, visits, milestones, consen...